Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs

Europe’s Next Act

European innovators helped pave the way for the world’s first COVID-19 vaccines. What’s coming next from Europe’s academic and biotech leaders?

  • What are the weathervane companies that point to where European innovation is headed?
  • What partnering deals are making the European highlight reel?
  • What innovations are investors finding and funding in Europe?
  • Can the U.K.’s split from the EU foster new opportunities for each side?

Join your colleagues for the 21st Bio€quity Europe as industry leaders debate these questions and identify where Europe will continue to provide global leadership in biopharma innovation.

COMING SOON: Schedule of Events

Registration includes:

  • Three days of strategic panels focused on Europe's Next Act
  • 60+ Presentations from European and Asian biotechs handpicked by BioCentury
  • 1x1 virtual partnering using EBD's PartneringOne System
  • European biotech executive report from Insights Partner, McKinsey & Co.
  • Opportunities for digital networking
  • Access to BioCentury business intelligence on European biotech and BioCentury BCIQ database to help you prepare for 1x1 virtual meetings with Presenting Companies and other attendees

Faculty

Karen Bernstein, Ph.D.
Chairman,
BioCentury Inc.
Simone Fishburn, Ph.D.
Vice President and Editor in Chief,
BioCentury Inc.
Carole Nuechterlein
Head, Roche Venture Fund,
Roche
Antoine Papiernik
Chairman and Managing Partner,
Sofinnova Partners
Jorge Santos da Silva, Ph.D.
Partner,
McKinsey & Company
View Faculty
right-arrow

Sponsors

ORGANIZERS
FOUNDING SPONSOR
INSIGHTS PARTNER
GOLD SPONSOR
SILVER SPONSORS
ACADEMIC SPINOUT CO-HOSTS
SUPPORTING ORGANIZATIONS
View Sponsors
right-arrow
Sponsorship Opportunities AvailableSpeak with a BioCentury representative today

Presenting Companies

Bio€quity Europe - Class of 2021
View Presenting Companies
right-arrow
Interested in becoming a Presenting Company?Apply now to be considered for the Bio€quity Europe Class of 2021

Testimonials

“Bio€quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe ... it is THE event where you can feel the pulse of the industry ...”

Antoine Papiernik
Chairman and Managing Partner,
Sofinnova Partners

"Bio€quity is for me the most important investor conference for life science in Europe. If you want to know how the investor community ticks and want to meet the most important companies and rising future stars in Europe it´s the place to be." ​

Harald Poth, Ph.D.
Senior Investment Manager,
LBBW Venture​

"If you are a VC or biotech CEO in Europe this is the conference to attend. Bio€quity is a great venue bringing the relevant players together. It’s not too big, not too small and it’s THE place to network." ​

Christina Takke, Ph.D.
Managing Partner,
V-Bio Ventures​